• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用MDS-NMS评估帕金森病非运动症状和非运动波动的患病率

Prevalence of Non-Motor Symptoms and Non-Motor Fluctuations in Parkinson's Disease Using the MDS-NMS.

作者信息

Rodriguez-Blazquez Carmen, Schrag Anette, Rizos Alexandra, Chaudhuri K Ray, Martinez-Martin Pablo, Weintraub Daniel

机构信息

National Centre of Epidemiology Carlos III Institute of Health Madrid Spain.

Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) Carlos III Institute of Health Madrid Spain.

出版信息

Mov Disord Clin Pract. 2020 Dec 21;8(2):231-239. doi: 10.1002/mdc3.13122. eCollection 2021 Feb.

DOI:10.1002/mdc3.13122
PMID:33553493
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7853195/
Abstract

BACKGROUND

Non-motor symptoms (NMS) are frequent in Parkinson's disease (PD).

OBJECTIVES

To estimate the prevalence of NMS and of non-motor fluctuations (NMF) using the Movement Disorders Society-Non-Motor Rating Scale (MDS-NMS) and other scales assessing NMS, and their relationship with sex and PD severity.

METHODS

Cross-sectional study with a sample of 402 PD patients. The Hoehn and Yahr staging system (HY), Clinical Impression of Severity Index for PD (CISI-PD), MDS-NMS (including NMF- subscale), Non-Motor Symptoms scale (NMSS), and MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) were applied. A NMS was considered present when scored ≥1. Differences in scores by sex and HY, CISI-PD, and MDS-UPDRS severity levels were calculated using Fisher's exact and chi-squared tests.

RESULTS

Using the MDS-NMS, NMS were present in 99.7% of patients and the mean number of NMS was 16.13 (SD: 9.36). The most prevalent NMS was muscle, joint or back pain (67.4% of the sample) and the least prevalent was dopamine dysregulation syndrome (2.2%). Feeling sad or depressed was significantly more prevalent in women. Using the MDS-NMS revealed more NMS than the other scales assessing NMS. NMF were present in 41% of the sample, with fatigue being the most prevalent symptom (68.5% patients with NMF), and no differences by sex. Patients with greater PD severity had higher prevalence of NMS than patients with lower severity.

CONCLUSIONS

Almost all patients with PD experience NMS, and many experience NMF. Prevalence rates for NMS using the MDS-NMS are higher than on other scales used and increase with higher disease severity.

摘要

背景

非运动症状(NMS)在帕金森病(PD)中很常见。

目的

使用运动障碍协会非运动症状评定量表(MDS-NMS)和其他评估NMS的量表,估计NMS和非运动波动(NMF)的患病率,以及它们与性别和PD严重程度的关系。

方法

对402例PD患者进行横断面研究。应用Hoehn和Yahr分期系统(HY)、PD严重程度临床印象指数(CISI-PD)、MDS-NMS(包括NMF子量表)、非运动症状量表(NMSS)和MDS统一帕金森病评定量表(MDS-UPDRS)。当评分≥1分时,认为存在NMS。使用Fisher精确检验和卡方检验计算性别、HY、CISI-PD和MDS-UPDRS严重程度水平的评分差异。

结果

使用MDS-NMS,99.7%的患者存在NMS,NMS的平均数量为16.13(标准差:9.36)。最常见的NMS是肌肉、关节或背痛(占样本的67.4%),最不常见的是多巴胺调节障碍综合征(2.2%)。女性中感到悲伤或抑郁的情况明显更普遍。使用MDS-NMS发现的NMS比其他评估NMS的量表更多。41%的样本存在NMF,疲劳是最常见的症状(68.5%的NMF患者),且无性别差异。PD严重程度较高的患者比严重程度较低的患者NMS患病率更高。

结论

几乎所有PD患者都有NMS,许多患者有NMF。使用MDS-NMS的NMS患病率高于其他使用的量表,且随着疾病严重程度的增加而升高。

相似文献

1
Prevalence of Non-Motor Symptoms and Non-Motor Fluctuations in Parkinson's Disease Using the MDS-NMS.使用MDS-NMS评估帕金森病非运动症状和非运动波动的患病率
Mov Disord Clin Pract. 2020 Dec 21;8(2):231-239. doi: 10.1002/mdc3.13122. eCollection 2021 Feb.
2
Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale.评估帕金森病的非运动症状:MDS-UPDRS 和 NMS 量表。
Eur J Neurol. 2015 Jan;22(1):37-43. doi: 10.1111/ene.12165. Epub 2013 Apr 22.
3
Real-World Nonmotor Changes in Patients with Parkinson's Disease and Motor Fluctuations: J-FIRST.帕金森病伴运动波动患者的真实世界非运动变化:J-FIRST研究
Mov Disord Clin Pract. 2020 Apr 11;7(4):431-439. doi: 10.1002/mdc3.12939. eCollection 2020 May.
4
Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease.帕金森病患者中MDS-UPDRS非运动项目与生活质量的关系
J Neurol Sci. 2015;353(1-2):87-91. doi: 10.1016/j.jns.2015.04.013. Epub 2015 Apr 17.
5
Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson's disease.帕金森病非运动症状量表意大利语版本的验证
Parkinsonism Relat Disord. 2017 Jan;34:38-42. doi: 10.1016/j.parkreldis.2016.10.020. Epub 2016 Oct 24.
6
Progression in Parkinson's Disease: Variation in Motor and Non-motor Symptoms Severity and Predictors of Decline in Cognition, Motor Function, Disability, and Health-Related Quality of Life as Assessed by Two Different Methods.帕金森病的进展:两种不同方法评估的运动和非运动症状严重程度的变化以及认知、运动功能、残疾和健康相关生活质量下降的预测因素。
Mov Disord Clin Pract. 2021 Jun 19;8(6):885-895. doi: 10.1002/mdc3.13262. eCollection 2021 Aug.
7
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort.早期帕金森病非运动症状的基线患病率及纵向演变:PPMI队列研究
J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):78-88. doi: 10.1136/jnnp-2017-316213. Epub 2017 Oct 6.
8
Non-motor symptom burden is strongly correlated to motor complications in patients with Parkinson's disease.帕金森病患者的非运动症状负担与运动并发症密切相关。
Eur J Neurol. 2020 Jul;27(7):1210-1223. doi: 10.1111/ene.14221. Epub 2020 Apr 24.
9
Assessing the relationship between non-motor symptoms and health-related quality of life in Parkinson's disease: a retrospective observational cohort study.评估帕金森病非运动症状与健康相关生活质量之间的关系:一项回顾性观察队列研究。
Neurol Sci. 2020 Oct;41(10):2867-2873. doi: 10.1007/s10072-020-04406-5. Epub 2020 Apr 23.
10
Self-Assessment of Disability in Parkinson's Disease: The MDS-UPDRS Part II Versus Clinician-Based Ratings.帕金森病残疾的自我评估:MDS-UPDRS 第二部分与基于临床医生的评分比较
Mov Disord Clin Pract. 2017 Jan 5;4(4):529-535. doi: 10.1002/mdc3.12462. eCollection 2017 Jul-Aug.

引用本文的文献

1
Predicting Cognitive Decline in Parkinson's Disease Using Artificial Neural Networks: An Explainable AI Approach.使用人工神经网络预测帕金森病的认知衰退:一种可解释的人工智能方法。
Brain Sci. 2025 Jul 23;15(8):782. doi: 10.3390/brainsci15080782.
2
Evaluation of Free-Living Motor Symptoms in Patients With Parkinson Disease Through Smartwatches: Protocol for Defining Digital Biomarkers.通过智能手表评估帕金森病患者的日常运动症状:定义数字生物标志物的方案
JMIR Res Protoc. 2025 Jul 28;14:e72820. doi: 10.2196/72820.
3
Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies.路易体痴呆显性和前驱期生物学框架的意义与机遇
Alzheimers Dement. 2025 Jul;21(7):e70470. doi: 10.1002/alz.70470.
4
Investigating the Inhibitory Potential of Halogenated Quinoline Derivatives against MAO‑A and MAO-B: Synthesis, Crystal Structure, Density Functional Theory, and Molecular Dynamics Simulations.研究卤代喹啉衍生物对单胺氧化酶-A和单胺氧化酶-B的抑制潜力:合成、晶体结构、密度泛函理论及分子动力学模拟
ACS Omega. 2025 Jun 13;10(25):26500-26519. doi: 10.1021/acsomega.4c11530. eCollection 2025 Jul 1.
5
Non-motor fluctuations in Parkinson's disease: frequency and clinical correlate.帕金森病的非运动波动:频率及临床关联
J Neural Transm (Vienna). 2025 Mar 13. doi: 10.1007/s00702-025-02908-0.
6
Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson's disease: guideline "Parkinson's disease" of the German Society of Neurology.帕金森病自主神经功能衰竭、疼痛及睡眠障碍的诊断与治疗:德国神经病学学会“帕金森病”指南
J Neurol. 2025 Jan 3;272(1):90. doi: 10.1007/s00415-024-12730-5.
7
Non-Motor Fluctuations in Parkinson's Disease: Underdiagnosed Yet Important.帕金森病的非运动波动:诊断不足但很重要。
J Mov Disord. 2025 Jan;18(1):1-16. doi: 10.14802/jmd.24227. Epub 2024 Dec 20.
8
Basal ganglia theta power indexes trait anxiety in people with Parkinson's disease.基底神经节θ波功率可反映帕金森病患者的特质焦虑。
Brain. 2025 Apr 3;148(4):1228-1241. doi: 10.1093/brain/awae313.
9
The effect of two speech and language approaches on speech problems in people with Parkinson's disease: the PD COMM RCT.两种言语语言治疗方法对帕金森病患者言语问题的影响:PD COMM RCT。
Health Technol Assess. 2024 Oct;28(58):1-141. doi: 10.3310/ADWP8001.
10
Visual mismatch negativity in Parkinson's psychosis and potential for testing treatment mechanisms.帕金森病性精神病中的视觉失配负波及测试治疗机制的潜力
Brain Commun. 2024 Sep 3;6(5):fcae291. doi: 10.1093/braincomms/fcae291. eCollection 2024.

本文引用的文献

1
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications.良性与恶性帕金森病:运动并发症意想不到的一线曙光。
J Neurol. 2020 Oct;267(10):2949-2960. doi: 10.1007/s00415-020-09954-6. Epub 2020 Jun 2.
2
The movement disorder society nonmotor rating scale: Initial validation study.运动障碍学会非运动症状评定量表:初步验证研究。
Mov Disord. 2020 Jan;35(1):116-133. doi: 10.1002/mds.27862. Epub 2019 Sep 30.
3
Motor and non-motor function predictors of mortality in Parkinson's disease.帕金森病患者死亡的运动和非运动功能预测因素。
J Neural Transm (Vienna). 2019 Nov;126(11):1409-1415. doi: 10.1007/s00702-019-02055-3. Epub 2019 Aug 5.
4
Emergence of non-motor fluctuations with reference to motor fluctuations in Parkinson's disease.帕金森病中非运动波动与运动波动的相关性。
Parkinsonism Relat Disord. 2018 Sep;54:79-83. doi: 10.1016/j.parkreldis.2018.04.020. Epub 2018 Apr 19.
5
Comprehensive grading of Parkinson's disease using motor and non-motor assessments: addressing a key unmet need.采用运动和非运动评估对帕金森病进行综合分级:满足一个关键的未满足需求。
Expert Rev Neurother. 2018 Jan;18(1):41-50. doi: 10.1080/14737175.2018.1400383. Epub 2017 Nov 7.
6
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort.早期帕金森病非运动症状的基线患病率及纵向演变:PPMI队列研究
J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):78-88. doi: 10.1136/jnnp-2017-316213. Epub 2017 Oct 6.
7
Parkinson's Disease Subtypes Identified from Cluster Analysis of Motor and Non-motor Symptoms.从运动和非运动症状聚类分析中识别出的帕金森病亚型
Front Aging Neurosci. 2017 Sep 20;9:301. doi: 10.3389/fnagi.2017.00301. eCollection 2017.
8
The Epidemiology of Nonmotor Symptoms in Parkinson's Disease (Cohort and Other Studies).帕金森病非运动症状的流行病学(队列研究及其他研究)
Int Rev Neurobiol. 2017;133:91-110. doi: 10.1016/bs.irn.2017.05.012. Epub 2017 Jun 27.
9
Measurement of Nonmotor Symptoms in Clinical Practice.临床实践中不自主运动症状的测量。
Int Rev Neurobiol. 2017;133:291-345. doi: 10.1016/bs.irn.2017.04.001. Epub 2017 Jun 1.
10
The range and nature of non-motor symptoms in drug-naive Parkinson's disease patients: a state-of-the-art systematic review.未经药物治疗的帕金森病患者非运动症状的范围和性质:一项最新的系统综述。
NPJ Parkinsons Dis. 2015 Jul 9;1:15013. doi: 10.1038/npjparkd.2015.13. eCollection 2015.